Facet Wealth’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$569K Buy
3,815
+1,011
+36% +$142K 0.01% 222
2026
Q2
$354K Sell
2,804
-46
-2% -$6.06K 0.01% 276
2026
Q1
$397K Buy
2,850
+591
+26% +$82.8K 0.01% 204
2025
Q4
$316K Buy
+2,259
New +$275K 0.01% 216

Other funds holding GILD

Facet Wealth's GILD Position: Q3 2026 in Review

Facet Wealth increased its Gilead Sciences (GILD) stake by 36% in Q3 2026, buying an estimated $142K and bringing the position to 3,815 shares worth $569K. The position accounts for 0.01% of the portfolio, ranked #222.

Facet Wealth first reported a position in GILD in Q4 2025 and has held it in 4 quarters since. 2,060 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Facet Wealth held 3,815 shares of Gilead Sciences worth $569K as of Q3 2026.
  • Facet Wealth bought 1,011 Gilead Sciences shares in Q3 2026, an estimated $142K.
  • Gilead Sciences made up 0.01% of Facet Wealth's portfolio in Q3 2026, its #222 holding.
  • Facet Wealth first reported a position in Gilead Sciences in Q4 2025 and has held it in 4 quarters since.
  • 2,060 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Facet Wealth's 13F filing for Q3 2026, filed 4 Nov 2026.